MDAI NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Spectral AI Inc. · Healthcare · Medical Devices

Open interactive chart View report data Download investor PDF
Latest close 1.64 USD
-1.8% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -5.9% below the Trend Line and sits at 25.7% of its 52-week range. The latest completed week returned -1.8%, after a -4.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 13d.

Setup score 19 out of 100
Latest Close 1.64 USD 24 Jul 2026
1W Return -1.8% latest completed week
4W Return -4.1% short-term follow-through
12W Return -23.7% quarterly tape
Trend Breadth 46.2% 24 of 52 weeks active
Volume Ratio 0.2x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.8% Latest completed week; four-week move -4.1%. Indicator stack 25/0 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 54/100 61 relevant articles in the latest sentiment read. Event risk 13d Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -5.9% below the Trend Line and sits at 25.7% of its 52-week range. The latest completed week returned -1.8%, after a -4.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4312-week average 0.53

12-week confirmation

Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.43Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.1% over four weeks, -23.7% over 12 weeks, and -36.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-1.8%
4W-4.1%
12W-23.7%
26W-5.7%
52W-36.9%
Active trend streak0 weeks
Active weeks in one year24
Trend breadth46.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.67Latest activity-pressure read.
Pressure change-4458.5%Four-week change in activity pressure.
Leadership-18.18Latest relative-leadership reading.
RS change18.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 73% Model confidence 70%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength37/100Blend of value, momentum, and quality. Underlying universe rank 64; rank 1 is best.
Value44/100Relative valuation strength. Underlying universe rank 57; rank 1 is best.
Quality42/100Profitability and accounting quality. Underlying universe rank 59; rank 1 is best.
Momentum44/100Medium-term price momentum. Underlying universe rank 57; rank 1 is best.
Growth44/100Revenue and earnings growth. Underlying universe rank 57; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
3.1x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-11.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
44.7%
Gross profit retained from each unit of revenue.
Operating margin
-78.5%
Operating profit retained from revenue.
Free-cash-flow margin
-35.4%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-44.3%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-14.5%
Net share repurchases relative to market value.
Shareholder yield
-14.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 61 relevant articles.

14 positive · 41 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings13dNext report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-44.8%Distance below the 52-week high.
13-week volatility9.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2614 weeks finished lower.
Best week+19.3%Week of 10 Apr.
Worst week-22.8%Week of 29 May.
Latest week-1.8%Week of 24 Jul.

Shape of recent returns

Strong gains8
Modest gains2
Flat weeks2
Modest losses8
Sharp losses6
Recent vol9.5%13-week weekly-return volatility.
Base vol9.3%52-week weekly-return volatility.
Up/down split21/28Count of positive and negative weeks in the 52-week window.
Average skew8.4% / -7.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape20/100

Trend, activity pressure, participation, and risk combine to a 20/100 tape read.

 Indicator analysis54/100

Latest 12-week confirmation: trend 9/12, activity pressure 8/12, relative leadership 3/12.

Activity pressure 0.43; No reversal markers Factors40/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 89; Small Cap Core rank 58 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment54/100

Weighted news tone is neutral across 61 relevant articles.

Spectral AI Inc (MDAI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution Insiders50/100

No recent insider transaction evidence is stored.

 Earnings13d

Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20261.64 USD-1.8%1.74 USD2.30 USD-0.67-18.18556.0KOff
17 Jul 20261.67 USD-2.9%1.74 USD2.35 USD-0.56-19.19977.5KOff
10 Jul 20261.72 USD-3.9%1.73 USD2.41 USD-0.38-21.291.0MOn
3 Jul 20261.79 USD4.7%1.73 USD2.47 USD-0.20-18.081.4MOn
26 Jun 20261.71 USD-6.0%1.72 USD2.52 USD0.02-22.201.5MOn
19 Jun 20261.82 USD0.0%1.72 USD2.58 USD0.44-21.631.2MOn
12 Jun 20261.82 USD-3.7%1.71 USD2.64 USD0.88-20.371.7MOn
5 Jun 20261.89 USD-8.7%1.70 USD2.69 USD1.28-16.023.4MOn
29 May 20262.07 USD-22.8%1.70 USD2.75 USD1.58-12.7511.6MOn
22 May 20262.68 USD10.3%1.70 USD2.80 USD1.6716.034.2MOn
15 May 20262.43 USD5.2%1.69 USD2.85 USD1.567.034.0MOn
8 May 20262.31 USD7.4%1.68 USD2.90 USD1.471.892.3MOff
1 May 20262.15 USD16.8%1.68 USD2.95 USD1.310.472.1MOff
24 Apr 20261.84 USD-2.6%1.68 USD3.01 USD0.97-12.381.9MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.